Seattle Children’s spins out BrainChild Bio, a startup developing therapies for incurable brain cancers
GeekWire
DECEMBER 5, 2023
The startup has an exclusive license to use novel CAR T-cell technology developed by Jensen and his team. BrainChild Bio will take with it about 18 people research and development employees from Seattle Children’s Therapeutics, which will continue working on childhood leukemia, lupus and other diseases.
Let's personalize your content